MedPath
NMPA Approval

Imipenem and Cilastatin Sodium for Injection

国药准字HJ20181007

August 5, 2022

H20181007

Drug Information

注射用亚胺培南西司他丁钠

泰能

泰能

注射剂

亚胺培南500mg和西司他丁500mg

化学药品

August 5, 2022

August 4, 2027

Company Information

Applicant Company

Merck, Inc.

126 E. Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065 United States of America

Manufacturing Company

Merck, Inc.

2778 South East Side Highway, Elkton, VA 22827 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用亚胺培南西司他丁钠 - NMPA 批准文号 | MedPath